REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,958,035 | -53.3% | 4,791,459 | +3.0% | 0.00% | -66.7% |
| Q2 2023 | $117,761,761 | -20.5% | 4,652,776 | +1.2% | 0.00% | -25.0% |
| Q1 2023 | $148,157,786 | +78.5% | 4,599,745 | +2.3% | 0.00% | +100.0% |
| Q4 2022 | $83,001,994 | -28.7% | 4,496,316 | +4.3% | 0.00% | -33.3% |
| Q3 2022 | $116,449,000 | +127.5% | 4,312,896 | +16.5% | 0.00% | +200.0% |
| Q2 2022 | $51,176,000 | -28.0% | 3,703,055 | +1.6% | 0.00% | -50.0% |
| Q1 2022 | $71,084,000 | +20.9% | 3,645,311 | +1.2% | 0.00% | +100.0% |
| Q4 2021 | $58,790,000 | -41.1% | 3,602,297 | +0.5% | 0.00% | -50.0% |
| Q3 2021 | $99,876,000 | -6.7% | 3,584,905 | -0.8% | 0.00% | -33.3% |
| Q2 2021 | $107,082,000 | +8.1% | 3,612,748 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $99,030,000 | +7.8% | 3,543,094 | +9.3% | 0.00% | 0.0% |
| Q4 2020 | $91,827,000 | +15.9% | 3,240,171 | +2.8% | 0.00% | 0.0% |
| Q3 2020 | $79,251,000 | +12.1% | 3,152,376 | +8.9% | 0.00% | 0.0% |
| Q2 2020 | $70,681,000 | +78.9% | 2,894,383 | +8.4% | 0.00% | +50.0% |
| Q1 2020 | $39,508,000 | -3.8% | 2,669,449 | +5.5% | 0.00% | +100.0% |
| Q4 2019 | $41,063,000 | +46.9% | 2,530,046 | +17.7% | 0.00% | 0.0% |
| Q3 2019 | $27,944,000 | -4.2% | 2,149,479 | -4.4% | 0.00% | 0.0% |
| Q2 2019 | $29,172,000 | -12.0% | 2,249,144 | +7.0% | 0.00% | 0.0% |
| Q1 2019 | $33,138,000 | -5.6% | 2,102,700 | +20.5% | 0.00% | -50.0% |
| Q4 2018 | $35,114,000 | -6.2% | 1,744,357 | +15.8% | 0.00% | +100.0% |
| Q3 2018 | $37,444,000 | -7.7% | 1,506,795 | +1.9% | 0.00% | -50.0% |
| Q2 2018 | $40,574,000 | -0.4% | 1,478,112 | +11.8% | 0.00% | 0.0% |
| Q1 2018 | $40,734,000 | -8.2% | 1,322,517 | +6.6% | 0.00% | 0.0% |
| Q4 2017 | $44,353,000 | +57.2% | 1,240,603 | +21.1% | 0.00% | +100.0% |
| Q3 2017 | $28,220,000 | +14.7% | 1,024,335 | +10.0% | 0.00% | 0.0% |
| Q2 2017 | $24,595,000 | +36.2% | 931,623 | +7.3% | 0.00% | 0.0% |
| Q1 2017 | $18,056,000 | +5.6% | 868,118 | +5.1% | 0.00% | 0.0% |
| Q4 2016 | $17,091,000 | +29.9% | 825,652 | +1.7% | 0.00% | 0.0% |
| Q3 2016 | $13,160,000 | +23.5% | 811,823 | +3.6% | 0.00% | 0.0% |
| Q2 2016 | $10,659,000 | -13.3% | 783,706 | +11.3% | 0.00% | 0.0% |
| Q1 2016 | $12,297,000 | -44.9% | 704,340 | +7.9% | 0.00% | 0.0% |
| Q4 2015 | $22,307,000 | +55.3% | 653,010 | +35.3% | 0.00% | 0.0% |
| Q3 2015 | $14,363,000 | +0.1% | 482,612 | +7.6% | 0.00% | 0.0% |
| Q2 2015 | $14,342,000 | +65.6% | 448,457 | +7.3% | 0.00% | 0.0% |
| Q1 2015 | $8,661,000 | +33.2% | 417,772 | +8.8% | 0.00% | – |
| Q4 2014 | $6,503,000 | +5.7% | 383,898 | +20.6% | 0.00% | – |
| Q3 2014 | $6,152,000 | -20.7% | 318,262 | +39.6% | 0.00% | -100.0% |
| Q2 2014 | $7,753,000 | +82.5% | 228,026 | +69.0% | 0.00% | – |
| Q1 2014 | $4,249,000 | – | 134,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |